CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8193311
APP PUB NO 20110207678A1
SERIAL NO

13021807

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An isolated polypeptide is provided. The isolated polypeptide comprising an antigen recognition domain capable of specifically binding a CD44 polypeptide as set forth in SEQ ID NO: 2 and incapable of binding a CD44 polypeptide selected from the group consisting of: SEQ ID NO: 4 or 6.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEMISRAEL JERUSALEM JERUSALEM JERUSALEM DISTRICT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Golan, Itshak Swansea, GB 9 35
Kessel, Irina Swansea, GB 4 25
Melnik, Lora Beit-Hashmonai, IL 8 30
Naor, David Jerusalem, IL 14 87
Nedvetzki, Shlomo Jerusalem, IL 6 33

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation